Mass Spectrometry for Peptides: Verifying Identity & Molecular Weight

Mass spectrometry answers the question HPLC purity cannot: which molecule is in the vial. It weighs the sample and matches the result against a target mass. That settles identity in one reading, unless two candidates happen to share a mass.

Several do. This page is organised around that split, because the useful thing to know is which side of it your compound sits on before you ask a vendor for a certificate. The homogeneity half of the problem belongs to what HPLC testing measures, and reading a real document field by field to how to read peptide lab test results. The growth hormone peptides category supplies both the cleanest win and one of the tightest margins.

What does mass spectrometry establish that HPLC cannot?

Mass spectrometry establishes identity. It measures mass-to-charge ratio and compares the result against a declared target, so a sermorelin sample either lands at 3,357.9 or it does not. HPLC purity reports the proportion of total peak area under the main peak and never records which species that peak was, which is why a vial of pure copper-free GHK at 340.38 daltons returns an excellent purity figure while carrying none of the copper its label claims.

The bottom two rows are the ones buyers cannot buy. Everything above them is purchasable, and the difference between the first two rows is the difference between a settled identity and an unsettled one on several named compounds.

When does mass spectrometry work brilliantly?

Whenever the two candidate molecules are separated by more than about a dalton, which covers most substitution risks in this market. Sermorelin at 3,357.9 sits 10 daltons from Mod GRF (1-29) at 3,367.9, and the Met27→Leu27 substitution producing that gap removes the molecule's only sulfur atom, so the two differ in elemental composition as well as mass. Tesamorelin at 5,136 Da sits 1,778 daltons above sermorelin. Kisspeptin-10 and kisspeptin-54 are 4,555 daltons apart.

Ten daltons is nothing to a purity certificate and everything to a mass spectrometer. The sermorelin case is the model: C₁₄₉H₂₄₆N₄₄O₄₂S against C₁₅₂H₂₅₂N₄₄O₄₂ is a binary an elemental composition report can answer, which converts an ambiguous ten-dalton margin into a yes or a no. Querying "CJC-1295" in chemical databases returns the DAC form at 3,647.2, so a vendor selling "CJC-1295" at 3,367.9 is selling Mod GRF (1-29) under a name belonging to a different molecule — and at 3,647.2 the DAC form sits far enough clear that no instrument confuses the two.

The kisspeptin case is the one where a trivially detectable gap is routinely left undetected. Every therapeutic kisspeptin trial from Imperial College London used kisspeptin-54; the market sells kisspeptin-10, a fragment with a half-life roughly six times shorter and no published human subcutaneous data. A 4,555-dalton separation is impossible to miss with MS and impossible to determine from a purity percentage alone. See sermorelin science, tesamorelin science and kisspeptin science.

When is a nominal mass not enough?

When the candidates sit inside about one dalton of each other, which is exactly the PT-141 case. Bremelanotide weighs 1,025.2 g/mol and melanotan II 1,024.18 — a separation of about 1.0 dalton on 1,025, under 0.1%, between an FDA-approved drug and a substance approved in no country. The two share an identical cyclic backbone, the same lactam bridge, the same D-phenylalanine and the same norleucine, differing only at the C-terminus: a free acid against a lysine amide.

A nominal-mass instrument reporting "1,025" is reporting a number it cannot defend to the decimal that matters. High-resolution mass spectrometry or MS/MS fragmentation resolves it and nothing cheaper does. The risk runs one way: someone ordering bremelanotide can receive melanotan II, while the reverse substitution costs a melanotan II buyer nothing.

There is a published forensic literature on exactly this substitution, and its existence is the argument. Mestria et al. (Drug Testing and Analysis, 2021) characterised black-market melanotan II and bremelanotide by LC-HRMS, and Breindahl et al. (Drug Testing and Analysis, 2015) identified and characterised melanotan II products sold illegally online. Forensic chemists do not develop high-resolution methods for markets without a discrimination problem. Detail sits in PT-141 and bremelanotide and melanotan II.

When does mass spectrometry fail outright?

When two candidates share a mass exactly, and three structural situations produce that. D and L amino acids have identical molecular formulas, identical molecular weights and identical monoisotopic masses. Misfolded protein has the same mass as correctly folded protein, so disulfide pairing is invisible. And a polydisperse PEGylated product has no single expected mass to match, returning an envelope rather than a peak.

FOXO4-DRI is the cleanest case of the first row, because the D configuration is not a detail — it is the entire design. A vial synthesised from ordinary L-amino acids would report roughly 5,358 Da, show a single clean peak, match every specification on a certificate and be degraded by serum proteases within minutes. SS-31 carries the same problem and its instructive opposite in one four-residue molecule: the Dmt→Tyr substitution is a clean −28 Da that MS catches, while D-Arg versus L-Arg is invisible to the same instrument.

The fourth row is the strangest and it belongs to IGF-1 LR3. Every vendor page quotes 83 amino acids and about 9,111 daltons, a full-text Europe PMC search for the quoted 13-residue extension MFPAMPLSSLFVN returns zero hits, and the founding 1992 paper describes 11 residues of methionyl porcine growth hormone rather than 13, which gives 81 residues rather than 83. Without a verified reference mass, an MS result reading "approximately 9,000 Da" is not an identity confirmation — and native IGF-1 at 7,649 Da, the figure on FDA's mecasermin label, would be easy to exclude if anyone knew what to exclude it against. See FOXO4-DRI science, SS-31 and elamipretide, IGF-1 LR3 science and PEG-MGF.

What is the difference between nominal-mass MS, high-resolution MS and MS/MS?

Resolution and information content. A nominal-mass instrument reports a rounded figure adequate for gaps of tens or hundreds of daltons — tesamorelin's 1,778 or kisspeptin's 4,555 — and inadequate below about a dalton. High-resolution MS reports mass to decimal places and supports an elemental composition, which is what converts sermorelin's 10-dalton margin into a sulfur-present-or-absent answer. MS/MS fragments the molecule and reads the pieces, reaching sequence-level questions neither of the others touches.

The practical instruction is narrow: ask which tier was run and whether it was run on your batch. A specimen certificate from an earlier lot describes a different vial, and substitution risk is per-batch rather than per-vendor.

Two further reading rules follow from mass alone. Terminal modifications change mass and are frequently identity-critical: gonadorelin's cyclised pyroglutamate and amidated C-terminal glycinamide are both required for receptor binding at 1,182.29 Da, and thymosin alpha-1's N-terminal acetyl is worth 42 daltons. And salt form changes the mass on the scale without changing the peptide, which is why MOTS-c is supplied at 2,174.6 free base, 2,234.64 acetate and 2,288.6 TFA salt — a 114-dalton spread, more than 5% of what is being weighed. See TFA versus acetate versus amidate salt forms.

Can mass spectrometry tell whether a peptide has degraded?

Yes, and this is where it earns its place on a certificate for compounds with no substitution risk at all. Methionine oxidation adds exactly 16 daltons per site, so MOTS-c at 2,174.6 free base reads 2,190.6 with one methionine oxidised and 2,206.6 with both, and VIP has the same vulnerability at Met21. A reduced oxytocin disulfide adds two hydrogen atoms, moving 1,007.19 to 1,009.19. HPLC purity sees none of it.

Those shifts are small in percentage terms and unambiguous in absolute terms, which is exactly what mass spectrometry is good at. A 16-dalton adduct on a 2,174.6-dalton molecule is 0.74% of the mass and a completely different chromatographic non-event. Glutathione is the extreme version: the oxidised dimer GSSG is not a damaged form of the 307.33-dalton monomer but a second compound with its own PubChem record, and a vial that has oxidised in storage can still return an excellent purity number against the wrong analyte.

The reading rule is to ask for the mass, not the percentage, on any sequence carrying an oxidation-labile residue or a disulfide bridge. Full degradation chemistry is in why a badly stored peptide still passes an HPLC purity test, with compound detail in MOTS-c science, oxytocin science and glutathione science.

Which claims about mass spectrometry survive scrutiny?

Three of nine. Mass spectrometry genuinely establishes identity against a declared target, genuinely resolves the substitutions this market actually runs, and genuinely detects mass-shifting degradation. Six fail: it does not confirm stereochemistry, does not see disulfide pairing, does not work without a reference mass, does not apply to undefined extracts, does not resolve one-dalton pairs at nominal resolution, and does not measure how much peptide is in the vial.

The sixth row is the one worth pausing on, because it is a failure of documentation rather than of instrumentation. Nothing is wrong with the mass spectrometer; there is simply no authoritative number to point it at, and the usual comparator is the same unsourced figure circulating on vendor pages.

What do Peptigrity's own records show about identity testing?

They show volume on the axis that does not settle identity. PT-141 is recorded at 99.70% average purity across 242 independent HPLC tests from Freedom Diagnostics, ILS, Kovera, Accurate Test Lab, MZ Biolabs and Ethos Analytics, across 225 verified shops (verified August 2026), with testing current to late July 2026. A 99.70% average is a genuinely strong result and the least informative figure on this compound, because a pure sample of melanotan II returns the same chromatogram.

Tesamorelin shows the opposite: 99.41% average HPLC purity across 497 independent tests from Bioviridian, Kovera, ILS and Freedom Diagnostics, across 227 verified vendors (verified August 2026), on a molecule whose 1,778-dalton separation from sermorelin makes identity a solved problem. Same platform, same test type, and a completely different amount of reassurance, decided by the mass gap rather than by the percentage.

PT-141 price data shows 65 shops in stock at a median of $4.40 per milligram, lowest $2.00/mg on a 10 mg vial and highest $9.59/mg on a 5 mg vial (verified 10 August 2026). Those figures exclude shipping, taxes and customs, coupon codes, bulk tiers, multi-vial kits and account-gated pricing. Quantity variance runs −3.3% to +16.3%, with the two overages measuring a 30 mg label at 34.9 mg and a 10 mg label at 11.63 mg, and endotoxin results are mostly absent. Those totals sit inside a platform tracking 530 shops and 11,852 independent lab tests across 118 peptides, with 1,283 community reviews (verified August 2026), weighted 50% community reviews and 50% independently verified lab purity. Compare vendors on the PT-141 compound page and the tesamorelin compound page, and search individual results in the lab test database.

How do you ask a vendor for an identity result worth having?

Ask for four things and treat the answers as data even when they are refusals: the instrument tier, a batch match, the target mass the result was read against, and the elemental composition where a gap is under about 20 daltons. A vendor who cannot say whether their mass spectrometry was nominal or high-resolution has not answered the PT-141 question, and a specimen certificate from an earlier lot has answered it about a different vial.

Two of those rows exist because of documented sequence ambiguity rather than vendor dishonesty. PEG-MGF's marketed sequence ends ...STFEEHK where UniProt's isoform 4 ends ...STFEERK, a 19-dalton difference on roughly 2,850, and at least one commercial supplier publishes a kisspeptin-54 sequence with arginine where UniProt Q15726 has proline. Verify sequences against the reference database rather than the vendor page, as red flags in peptide certificates of analysis and third-party peptide testing labs set out.

The trial that would settle whether nominal-mass MS is enough

Nobody has submitted matched pairs of these near-isobaric compounds to the laboratories serving this market and reported how often the reported mass was right. Forensic groups have published high-resolution methods for the melanotan II and bremelanotide pair, which establishes that the discrimination is hard rather than how often it is got wrong on a commercial certificate. That distinction is the honest state of the evidence.

What a mass spectrum is worth on your compound

Mass spectrometry is the strongest routine identity tool available to this market and it is not a general-purpose guarantee. Its value is set almost entirely by the size of the gap between your compound and its nearest substitute: enormous at 4,555 daltons, decisive at 10 daltons with an elemental composition beside it, and absent at zero — which is where stereochemistry and disulfide pairing sit, permanently, whatever instrument is used.

The practical order is to identify the nearest substitute first, then work out what gap separates them, then ask for the tier of instrument that gap requires. On compounds where the answer is zero daltons, no certificate resolves it and the honest position is to say so rather than to accept a purity percentage in its place.

Browse the growth hormone peptides and libido and sexual wellness peptides categories, or our complete peptide guide with 118 compounds (verified August 2026). For per-injection volume, use the tesamorelin calculator alongside the reconstitution calculator, and check current cost through tesamorelin price data. Compare shops through independent lab tests and community-verified shop reviews.

Frequently Asked Questions

Does a mass spectrometry result prove I received the right peptide?

Usually, and not always. It proves the measured mass matches a declared target, which settles identity wherever the nearest substitute differs by more than about a dalton. It settles nothing where the substitute is isobaric — a D-amino acid version, a misfolded protein, or melanotan II at 1,024.18 against bremelanotide at 1,025.2 on a nominal-mass instrument.

What is the difference between nominal and high-resolution mass spectrometry?

Decimal places, and what they buy. Nominal-mass MS reports a rounded figure, adequate for the 1,778-dalton gap between tesamorelin and sermorelin or the 4,555 daltons between kisspeptin-54 and kisspeptin-10. High-resolution MS reports mass to the decimal and supports elemental composition, which is what turns sermorelin's 10-dalton margin into a sulfur-present-or-absent answer.

Why can mass spectrometry not detect D-amino acids?

Because D and L residues are identical in formula, molecular weight and monoisotopic mass. They also co-elute on standard reversed-phase columns, so neither routine test reaches the question. FOXO4-DRI's all-D configuration and SS-31's D-arginine both fall in this gap, and only chiral chromatography or amino acid analysis with chiral derivatisation resolves it.

Can mass spectrometry confirm a peptide is folded correctly?

No. Misfolded protein has the same mass as correctly folded protein, so disulfide pairing is invisible to the instrument. That matters most for IGF-1 analogues, where three intramolecular bridges must form in the correct pairing and an incorrectly folded product is mass-identical and biologically inactive. No routine test in this market reports it.

Why does IGF-1 LR3 have a reference mass problem?

Because the number everyone quotes has no source we could find. A full-text Europe PMC search for the quoted 13-residue extension returns zero hits, and the founding 1992 paper describes 11 residues rather than 13, giving 81 amino acids rather than 83. Without a verified target, a result reading "approximately 9,000 Da" confirms nothing.

Should I accept a certificate with purity but no mass result?

Only on compounds where identity is not the risk. Where the nearest substitute is a different molecule — copper-free GHK, Mod GRF, kisspeptin-10, melanotan II, native IGF-1 — a purity percentage answers a question you were not asking. Request a batch-matched mass result with the target mass and instrument tier stated.

This article is for educational and informational purposes only and does not constitute medical advice. Peptides discussed may be investigational compounds not approved by the FDA (or equivalent regulators in your jurisdiction) for human use. Always consult a qualified healthcare provider before using any peptide or research compound. Peptigrity is an independent review platform and does not sell, endorse, or recommend specific products or vendors.